U.S. Dominates Publishing 0f Genome Mapping Articles

Between 1977 and 1986, the United States produced more than 42% of all articles on mapping and sequencing the human genome that appeared in 3,200 of the world’s leading scientific journals, the Congressional Office of Technology Assessment (OTA) reported in a study issued in late April. “The United States is the clear leader in basic research, publishing more articles on mapping and sequencing than European or Asian nations,” it concluded. The next largest contributor over t

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The next largest contributor over this period was the United Kingdom, whose researchers produced 9.1% of some 10,000 papers surveyed. France ranked third at 6.1%, West Germany fourth at 4.6%, USSR and Eastern Europe fifth at 3.9%, Japan sixth at 3.9%, Canada seventh at 3.1%, and all others less than 3% each (see chart).

There was some variation year to year in percentage share. For example, the U.S. contributed 46% in 1983 compared with 38% in 1979. Japan increased its share steadily over the decade, from 2% in 1977 to 5% in 1986. Otherwise, the year-by-year percentages are generally consistent for each nation.

The total number of articles on gene mapping, however, more than quadrupled over the decade—from approxunately 400 in 1977 to nearly 1,900 in 1988.

The bibliometric analysis was performed for OTA by Computer Horizons inc., an independent New Jersey-based research company. CHI, using data from the National ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies